Kiwa Bio-tech Products Group Corp (KWBT) financial statements (2021 and earlier)
Company profile
| Business Address |
3200 GUASTI ROAD, ONTARIO, CA 91761 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| SIC | 287 - Agricultural Chemicals (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 8 | 1,084 | 13 | 1 | |||
| Cash and cash equivalents | 8 | 1,084 | 13 | 1 | |||
| Receivables | 6,763 | 48 | 1,123 | ||||
| Inventory, net of allowances, customer advances and progress billings | 1,643 | 2,746 | |||||
| Inventory | 1,643 | 2,746 | |||||
| Prepaid expense | 2,260 | 2,474 | 1,418 | ||||
| Deferred costs | 4,930 | 17 | |||||
| Other undisclosed current assets | 16,087 | 12,705 | 1,919 | 47 | |||
| Total current assets: | 31,690 | 19,073 | 4,473 | 48 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 93 | 91 | 55 | 3 | |||
| Long-term investments and receivables | 727 | 768 | 1,522 | ||||
| Long-term investments | 727 | 768 | |||||
| Due from related parties | 1,522 | ||||||
| Deposits noncurrent assets | 1 | 73 | 35 | ||||
| Total noncurrent assets: | 821 | 931 | 1,612 | 3 | |||
| TOTAL ASSETS: | 32,511 | 20,005 | 6,085 | 51 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 7,604 | 4,991 | 4,168 | 3,341 | |||
| Accounts payable | 1,611 | 1,801 | 1,073 | 300 | |||
| Employee-related liabilities | 1,025 | 291 | 1,155 | 1,633 | |||
| Taxes payable | 2,947 | 1,143 | 415 | 478 | |||
| Interest and dividends payable | 2,021 | 1,756 | 1,525 | 930 | |||
| Debt | 360 | 360 | 360 | 360 | |||
| Derivative instruments and hedges, liabilities | 7 | 248 | |||||
| Due to related parties | 571 | 261 | 4,310 | ||||
| Disposal group, including discontinued operation | 4,465 | ||||||
| Deferred revenue and credits | ✕ | ✕ | 29 | ||||
| Contract with customer, liability | ✕ | 6,751 | ✕ | ✕ | ✕ | ||
| Other liabilities | 2,940 | 2,109 | 925 | 524 | |||
| Other undisclosed current liabilities | 1,552 | 1,137 | 150 | 843 | |||
| Total current liabilities: | 19,785 | 8,874 | 10,329 | 9,378 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 460 | 1,773 | |||||
| Long-term debt, excluding current maturities | 460 | 1,773 | |||||
| Total noncurrent liabilities: | 460 | 1,773 | |||||
| Total liabilities: | 19,785 | 9,334 | 10,329 | 11,151 | |||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | 12,727 | 10,671 | (4,244) | (11,100) | |||
| Preferred stock | 1 | 1 | |||||
| Common stock | 17 | 15 | 9 | 2 | |||
| Common stock, share subscribed but unissued, subscriptions receivable | (1,023) | 458 | 127 | ||||
| Additional paid in capital | 27,047 | 24,455 | 15,235 | 9,491 | |||
| Accumulated other comprehensive income (loss) | (558) | 324 | (54) | (269) | |||
| Accumulated deficit | (14,804) | (14,583) | (19,561) | (20,325) | |||
| Other undisclosed stockholders' equity attributable to parent | 2,047 | 1 | |||||
| Total stockholders' equity: | 12,727 | 10,671 | (4,244) | (11,100) | |||
| TOTAL LIABILITIES AND EQUITY: | 32,511 | 20,005 | 6,085 | 51 | |||
Income statement (P&L) ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|
| Revenues | 30,650 | 17,270 | 9,621 | |||
| Cost of revenue (Cost of Goods and Services Sold) | (22,392) | (11,846) | (7,200) | |||
| Gross profit: | 8,258 | 5,424 | 2,421 | |||
| Operating expenses | (5,669) | (3,628) | (1,548) | (493) | ||
| Operating income (loss): | 2,589 | 1,796 | 873 | (493) | ||
| Nonoperating income (expense) | (339) | 121 | 594 | 185 | ||
| Foreign currency transaction gain (loss), before tax | 55 | (59) | ||||
| Interest and debt expense | (635) | (524) | (90) | 113 | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 635 | 524 | ||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 2,250 | 1,917 | 1,376 | (195) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 90 | (482) | ||||
| Income (loss) from continuing operations before income taxes: | 2,250 | 1,917 | 1,466 | (677) | ||
| Income tax expense (benefit) | 1,906 | 1,103 | (425) | |||
| Other undisclosed loss from continuing operations | (3,812) | (2,207) | ||||
| Income (loss) from continuing operations: | 344 | 814 | 1,042 | (677) | ||
| Income (loss) from discontinued operations | 4,495 | (150) | ||||
| Net income (loss) available to common stockholders, diluted: | 344 | 5,309 | 891 | (677) | ||
Comprehensive Income ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | 344 | 5,309 | 891 | (677) | ||
| Other comprehensive income (loss) | (882) | 378 | 215 | 424 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (538) | 5,687 | 1,106 | (253) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.